Contact

Herceptin Access Solutions

Herceptin Access Solutions is a reimbursement resource designed to address the informational needs of patients on Genentech products related to reimbursement. Herceptin Access Solutions provides information to doctors, on their patient's behalf, in order to help obtain timely reimbursement.

  • Genentech Corporate Headquarters
  • Phone: (650) 225-1000
  • Fax: (650) 225-6000
  • Mail: Genentech, Inc.
  • 1 DNA Way, Mail Stop #210
  • South San Francisco, CA 94080-4990


Herceptin® (trastuzumab)Herceptin® (trastuzumab)

Adjuvant Care Is defined as additional treatment given after the main treatment plan to decrease the chance of recurrence. Adjuvant therapy for breast cancer can include chemotherapy, hormone therapy, radiation therapy, or biological therapy

Metastatic Breast Cancer Breast cancer that has spread to other sites in the body; also referred to as invasive or infiltrating

close

Share this page


Email this page